Indeed, a similar GEMM employing an activated Smo under a ubiquitously expressed inducible driver leads to widespread neoplastic lesions, including, but not limited to, medulloblastoma in 40% of cases (47). The gene discussed is SMO; the disease is medulloblastoma.